FG-26-099: FY 2026 Congressionally Directed Spending Projects
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2026.
Substance Abuse and Mental Health Services Adminis offered grants of up to $3.0 million to the applicants described in the notice. It expected to make about 79 awards worth $54.3 million in total. Applications closed on July 13, 2026.
From the official notice on Grants.gov, last changed June 12, 2026. Checked November 7, 2026.
- Award ceiling$3.0 million
- Total funding$54.3 million
- Expected awards79
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| FG-24-099 | April 22, 2024 | Closed June 21, 2024 | Closed |
Key dates
| Posted | June 12, 2026 |
|---|---|
| Deadline | July 13, 2026 |
| Archived by Grants.gov | August 12, 2026 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible entities are the organizations identified in the Joint Explanatory Statement accompanying the FY 2026 Consolidated Appropriations Act [Public Law No: 119-75] as SAMHSA funded Congressionally Directed Spending Projects. This announcement is not open to the public.
Is this a realistic fit?
- Past Congressional Directives awards averaged $1.5 million; this notice allows up to $3.0 million per award.
- No cost sharing or match is required.
What the grant funds
The purpose of this funding opportunity is to provide general information to organizations identified as Congressionally Directed Spending (CDS) Projects in the Consolidated Appropriations Act, 2026. Note: Award amounts for the CDS Projects are included in Appendix A of the NOFO.
Who has won Congressional Directives grants before
From fiscal 2021 to 2025, Congressional Directives (93.493) awarded $4.0 billion across 2,688 grant awards, an average of $1.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of Alabama at Birmingham | Alabama | 2 | $152 million |
| University of Missouri System | Missouri | 2 | $122 million |
| Missouri State University | Missouri | 3 | $62.5 million |
| University of Kansas Medical Center Research Institute, Inc. | Kansas | 6 | $41.6 million |
| Spring Hill College | Alabama | 1 | $35.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is FG-26-099 still open?
No. It closed on July 13, 2026.
Who can apply for FY 2026 Congressionally Directed Spending Projects?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for FY 2026 Congressionally Directed Spending Projects?
Closed July 13, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $3.0 million each. About $54.3 million in total across about 79 awards.
Who has won Congressional Directives grants before?
The largest recipients over five fiscal years were University of Alabama at Birmingham, University of Missouri System, Missouri State University. The program made 2,688 awards worth $4.0 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)